Related Experiment Videos

Antiretroviral rounds. A very discordant response

Keith Henry¹, Elizabeth Jenny-Avital

¹HIV Program and Clinic, Regions Hospital, St. Paul, USA.

AIDS Clinical Care

|January 23, 2002

Abstract

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Efficacy and safety of switch to bictegravir/emtricitabine/tenofovir alafenamide from dolutegravir/abacavir/lamivudine: Results from an open-label extension of a phase 3 randomized, double-blind, multicenter, active-controlled, non-inferiority study.

Medicine·2025

Long-Term Benefits from Early Antiretroviral Therapy Initiation in HIV Infection.

NEJM evidence·2023

Long-term safety and efficacy of emtricitabine and tenofovir alafenamide vs emtricitabine and tenofovir disoproxil fumarate for HIV-1 pre-exposure prophylaxis: week 96 results from a randomised, double-blind, placebo-controlled, phase 3 trial.

The lancet. HIV·2021

Frequency of post treatment control varies by antiretroviral therapy restart and viral load criteria.

AIDS (London, England)·2021

Prevalence, Incidence, and Clearance of Human Papillomavirus Types Covered by Current Vaccines in Men With Human Immunodeficiency Virus in the SUN Study.

The Journal of infectious diseases·2019

HIV Care Trajectories as a Novel Longitudinal Assessment of Retention in Care.

AIDS and behavior·2019

See all related articles